Home

Brian Druker

CIK 1740205 · last filed 2026-05-21

Brian Druker is a corporate insider who has filed 14 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for AMGN, was dated May 21, 2026. Current disclosed insider exposure totals $3.2M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.23M

Companies

3

Total Filings

14

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMGN Director 8,391 $385.16 $3.23M $0 9 2026-05-21
Vincerx Pharma, Inc. (VINC) Delisted Director — $0.01 — $0 4 2024-05-28
Vincerx Pharma, Inc. (VINCW) Delisted Director 54,806 $1.61 $88.2K $0 1 2020-12-28

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-21 AMGN Grant (A) +665 $0 EDGAR
2025-05-28 AMGN Grant (A) +809 $0 EDGAR
2024-06-04 AMGN Grant (A) +719 $0 EDGAR
2024-05-28 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2023-05-30 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2023-05-23 AMGN Grant (A) +939 $0 EDGAR
2022-05-31 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
2022-05-19 AMGN Grant (A) +855 $0 EDGAR
2021-05-20 AMGN Grant (A) +837 $0 EDGAR
2021-05-14 Vincerx Pharma, Inc. (VINC) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.